ETFMG Treatments, Testing and Advancements ETF
Not enough financial coverage to compute a composite score for GERM. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The index tracks the performance of U. S. -listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients.
- IPO
- 2020
- HQ
- DE, US
Price Chart
Performance & Tape
- 52W High
- $20.20
- 52W Low
- $16.32
- 50D MA
- $18.93
- 200D MA
- $18.53
- Beta
- 1.02
- Avg Volume
- 1.20K
Get TickerSpark's AI analysis on GERM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GERM Coverage
We haven't published any research on GERM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GERM Report →